List of Tables
Table 1. Global Checkpoint Inhibitors for Treating Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Checkpoint Inhibitors for Treating Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Checkpoint Inhibitors for Treating Cancer Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Checkpoint Inhibitors for Treating Cancer Sales by Region (2020-2025) & (K Units)
Table 5. Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Checkpoint Inhibitors for Treating Cancer Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Checkpoint Inhibitors for Treating Cancer Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Checkpoint Inhibitors for Treating Cancer Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Checkpoint Inhibitors for Treating Cancer Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Checkpoint Inhibitors for Treating Cancer Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Checkpoint Inhibitors for Treating Cancer Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Checkpoint Inhibitors for Treating Cancer Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Checkpoint Inhibitors for Treating Cancer Sales Share by Manufacturer (2020-2025)
Table 18. Checkpoint Inhibitors for Treating Cancer Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Checkpoint Inhibitors for Treating Cancer Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Checkpoint Inhibitors for Treating Cancer Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Checkpoint Inhibitors for Treating Cancer Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Checkpoint Inhibitors for Treating Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Checkpoint Inhibitors for Treating Cancer as of 2024)
Table 24. Checkpoint Inhibitors for Treating Cancer Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Checkpoint Inhibitors for Treating Cancer Market
Table 26. Manufacturers Checkpoint Inhibitors for Treating Cancer Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Bristol-Myers Squibb(BMS) Company Information
Table 29. Bristol-Myers Squibb(BMS) Description and Business Overview
Table 30. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Product
Table 31. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Bristol-Myers Squibb(BMS) Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Product in 2024
Table 33. Bristol-Myers Squibb(BMS) Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Application in 2024
Table 34. Bristol-Myers Squibb(BMS) Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Geographic Area in 2024
Table 35. Bristol-Myers Squibb(BMS) Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Checkpoint Inhibitors for Treating Cancer Product
Table 39. Merck Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Product in 2024
Table 41. Merck Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Application in 2024
Table 42. Merck Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. Roche Company Information
Table 45. Roche Description and Business Overview
Table 46. Roche Checkpoint Inhibitors for Treating Cancer Product
Table 47. Roche Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Roche Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Product in 2024
Table 49. Roche Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Application in 2024
Table 50. Roche Sales Proportion of Checkpoint Inhibitors for Treating Cancer by Geographic Area in 2024
Table 51. Roche Recent Developments
Table 52. North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2020-2025) & (K Units)
Table 53. North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2026-2031) & (K Units)
Table 54. North America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 55. North America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 56. North America Checkpoint Inhibitors for Treating Cancer Sales by Type (2020-2025) & (K Units)
Table 57. North America Checkpoint Inhibitors for Treating Cancer Sales by Application (2020-2025) & (K Units)
Table 58. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Region (2020-2025) & (K Units)
Table 59. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Region (2026-2031) & (K Units)
Table 60. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Region (2020-2025) & (US$ Million)
Table 61. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Region (2026-2031) & (US$ Million)
Table 62. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Type (2020-2025) & (K Units)
Table 63. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales by Application (2020-2025) & (K Units)
Table 64. Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2020-2025) & (K Units)
Table 65. Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2026-2031) & (K Units)
Table 66. Europe Checkpoint Inhibitors for Treating Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 67. Europe Checkpoint Inhibitors for Treating Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 68. Europe Checkpoint Inhibitors for Treating Cancer Sales by Type (2020-2025) & (K Units)
Table 69. Europe Checkpoint Inhibitors for Treating Cancer Sales by Application (2020-2025) & (K Units)
Table 70. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Country (2020-2025) & (K Units)
Table 71. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Country (2026-2031) & (K Units)
Table 72. Latin America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 73. Latin America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 74. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Type (2020-2025) & (K Units)
Table 75. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Application (2020-2025) & (K Units)
Table 76. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2020-2025) & (K Units)
Table 77. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2026-2031) & (K Units)
Table 78. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 79. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 80. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales by Type (2020-2025) & (K Units)
Table 81. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales by Application (2020-2025) & (K Units)
Table 82. Checkpoint Inhibitors for Treating Cancer Key Raw Materials, Industry Status and Trend
Table 83. Checkpoint Inhibitors for Treating Cancer Key Raw Materials and Upstream Suppliers
Table 84. Checkpoint Inhibitors for Treating Cancer Clients Status and Trend
Table 85. Checkpoint Inhibitors for Treating Cancer Typical Clients
Table 86. Checkpoint Inhibitors for Treating Cancer Distributors
Table 87. Checkpoint Inhibitors for Treating Cancer Market Trends
Table 88. Checkpoint Inhibitors for Treating Cancer Market Drivers
Table 89. Checkpoint Inhibitors for Treating Cancer Market Challenges
Table 90. Checkpoint Inhibitors for Treating Cancer Market Restraints
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Checkpoint Inhibitors for Treating Cancer Product Picture
Figure 2. Global Checkpoint Inhibitors for Treating Cancer Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type in 2024 & 2031
Figure 4. PD-1 Inhibitors Product Picture
Figure 5. PD-L1 Inhibitors Product Picture
Figure 6. CTLA-4 Inhibitors Product Picture
Figure 7. Global Checkpoint Inhibitors for Treating Cancer Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application in 2024 & 2031
Figure 9. Melanoma Treatment
Figure 10. Bladder Cancer Treatment
Figure 11. Other
Figure 12. Checkpoint Inhibitors for Treating Cancer Report Years Considered
Figure 13. Global Checkpoint Inhibitors for Treating Cancer Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Checkpoint Inhibitors for Treating Cancer Market Size 2020-2031 (US$ Million)
Figure 15. Global Checkpoint Inhibitors for Treating Cancer Sales 2020-2031 (K Units)
Figure 16. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2020-2031)
Figure 18. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Checkpoint Inhibitors for Treating Cancer Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Checkpoint Inhibitors for Treating Cancer Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. PD-1 Inhibitors of Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Application, 2024 VS 2031
Figure 25. PD-L1 Inhibitors of Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Application, 2024 VS 2031
Figure 26. CTLA-4 Inhibitors of Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Checkpoint Inhibitors for Treating Cancer Sales Share by Manufacturer in 2024
Figure 28. Checkpoint Inhibitors for Treating Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. PD-1 Inhibitors Market Sales Proportion by Manufacturer in 2024
Figure 30. PD-L1 Inhibitors Market Sales Proportion by Manufacturer in 2024
Figure 31. CTLA-4 Inhibitors Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Checkpoint Inhibitors for Treating Cancer Revenue 2020-2031 (US$ Million)
Figure 33. North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2020-2025)
Figure 34. North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2020-2025)
Figure 40. Europe Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2020-2031)
Figure 42. Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2020-2031)
Figure 43. Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2020-2025)
Figure 44. Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2020-2025)
Figure 45. Latin America Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2020-2031)
Figure 47. Latin America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2020-2025)
Figure 49. Latin America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2020-2025)
Figure 55. Checkpoint Inhibitors for Treating Cancer Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Checkpoint Inhibitors for Treating Cancer Raw Materials by Region in 2024
Figure 57. Checkpoint Inhibitors for Treating Cancer Distribution Channels
Figure 58. Global Checkpoint Inhibitors for Treating Cancer Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Checkpoint Inhibitors for Treating Cancer Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
